These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10552024)

  • 1. Normal-appearing white matter in optic neuritis and multiple sclerosis: a comparative proton spectroscopy study.
    Tourbah A; Stievenart JL; Abanou A; Iba-Zizen MT; Hamard H; Lyon-Caen O; Cabanis EA
    Neuroradiology; 1999 Oct; 41(10):738-43. PubMed ID: 10552024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Permeability of the blood-brain barrier predicts conversion from optic neuritis to multiple sclerosis.
    Cramer SP; Modvig S; Simonsen HJ; Frederiksen JL; Larsson HB
    Brain; 2015 Sep; 138(Pt 9):2571-83. PubMed ID: 26187333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
    Suhy J; Rooney WD; Goodkin DE; Capizzano AA; Soher BJ; Maudsley AA; Waubant E; Andersson PB; Weiner MW
    Mult Scler; 2000 Jun; 6(3):148-55. PubMed ID: 10871825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized proton magnetic resonance spectroscopy in relapsing remitting versus secondary progressive multiple sclerosis.
    Tourbah A; Stievenart JL; Gout O; Fontaine B; Liblau R; Lubetzki C; Cabanis EA; Lyon-Caen O
    Neurology; 1999 Sep; 53(5):1091-7. PubMed ID: 10496272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain macro- and microscopic damage in patients with paediatric MS.
    Absinta M; Rocca MA; Moiola L; Ghezzi A; Milani N; Veggiotti P; Comi G; Filippi M
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1357-62. PubMed ID: 20660915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis.
    Brex PA; Gomez-Anson B; Parker GJ; Molyneux PD; Miszkiel KA; Barker GJ; MacManus DG; Davie CA; Plant GT; Miller DH
    J Neurol Sci; 1999 Jun; 166(1):16-22. PubMed ID: 10465494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopic imaging in multiple sclerosis.
    Tedeschi G; Bonavita S; McFarland HF; Richert N; Duyn JH; Frank JA
    Neuroradiology; 2002 Jan; 44(1):37-42. PubMed ID: 11942498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study.
    Bellmann-Strobl J; Stiepani H; Wuerfel J; Bohner G; Paul F; Warmuth C; Aktas O; Wandinger KP; Zipp F; Klingebiel R
    Eur Radiol; 2009 Aug; 19(8):2066-74. PubMed ID: 19308417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
    Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
    J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging axonal damage of normal-appearing white matter in multiple sclerosis.
    Fu L; Matthews PM; De Stefano N; Worsley KJ; Narayanan S; Francis GS; Antel JP; Wolfson C; Arnold DL
    Brain; 1998 Jan; 121 ( Pt 1)():103-13. PubMed ID: 9549491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corpus callosum axonal injury in multiple sclerosis measured by proton magnetic resonance spectroscopic imaging.
    Oh J; Pelletier D; Nelson SJ
    Arch Neurol; 2004 Jul; 61(7):1081-6. PubMed ID: 15262739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Metabolite Changes in Patients with Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: A Two-Year Follow-Up Study.
    Obert D; Helms G; Sättler MB; Jung K; Kretzschmar B; Bähr M; Dechent P; Diem R; Hein K
    PLoS One; 2016; 11(9):e0162583. PubMed ID: 27636543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric optic neuritis: brain MRI abnormalities and risk of multiple sclerosis.
    Bonhomme GR; Waldman AT; Balcer LJ; Daniels AB; Tennekoon GI; Forman S; Galetta SL; Liu GT
    Neurology; 2009 Mar; 72(10):881-5. PubMed ID: 19273821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1H MRSI of normal appearing white matter in multiple sclerosis.
    Rooney WD; Goodkin DE; Schuff N; Meyerhoff DJ; Norman D; Weiner MW
    Mult Scler; 1997 Aug; 3(4):231-7. PubMed ID: 9372505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning.
    EkŞİ Z; ÇakiroĞlu M; Öz C; AralaŞmak A; Karadelİ HH; Özcan ME
    Arq Neuropsiquiatr; 2020 Dec; 78(12):789-796. PubMed ID: 33331515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging.
    Peters AR; Geelen JA; den Boer JA; Prevo RL; Minderhoud JM; 's Gravenmade EJ
    Mult Scler; 1995 Apr; 1(1):25-31. PubMed ID: 9345466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.